Labcorp's Clinical Trial Management Systems (CTMS) act as a central repository for operational data, supports streamlining operations and enables the detection of project plan variances and identification of potential problems.

Labcorp Drug Development's Market Access Consulting team can advise and provide support in the design, development and implementation of your digital transformation needs in market access, starting with an initial needs assessment and a recommendation of how best to make use of available digital technologies to bolster and support successful execution of y

This article explores the field of NH studies, explaining what they are and how they can be used to build faster, more efficient, patient-centric trials with a better chance of success and approval, both for rare diseases and the wider drug development market.

LIVe 2022 -- There is a current push to investigate the toxicity of emerging Next Generation Products (NGPs) including Electronic Nicotine Delivery System (ENDS) and Heated Tobacco Product (HTP) products. 3D airway tissue models are a relevant method for analysis of toxicity for these aerosol products.

Continued growth in the development of large molecule therapeutics has constrained resources for in vivo studies and in vitro sample analysis.

STP 2022 -- Sprague Dawley (SD) rats are commonly used in toxicologic pathology studies and frequently the rodent choice for two-year (104-week) carcinogenicity studies. It is important to accurately identify rare and common spontaneous neoplasms for proper assessment of the carcinogenic potential of the test article in such studies.

STP 2022 -- In an effort to better align the positioning of clinical pathology findings in reports and regulatory documents amongst the global clinical pathology toxicologic pathology community, this European Society of Toxicologic Pathology (ESTP) Working Group was formed to discuss the inconsistent utilization of terms such as "biological relevance" and

STP 2022 -- Sprague Dawley (SD) rats are commonly used in toxicologic pathology studies and frequently the rodent choice for two-year (104-week) carcinogenicity studies. It is important to accurately identify rare and common spontaneous neoplasms for proper assessment of the carcinogenic potential of the test article in such studies.

STP 2022 -- Historical control data are important tools used in toxicologic pathology for the evaluation and interpretation of neoplastic and nonneoplastic findings reported during rodent carcinogenicity studies.

Large clinical trials demand experience managing complex organizational requirements to synchronize many moving parts. In the past, Labcorp Drug Development has successfully conducted 14 global mega-trials involving cardiovascular outcomes.